Drugs of Abuse Testing Market Size by Product & Service, Sample Type, End Users, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2029

8.3%
CAGR (2023-2029)
9.35 USD Bn.
Market Size
328
Report Pages
152
Market Tables

Overview

Drugs of Abuse Testing Market size is expected to grow at a CAGR of 8.30% during the forecast period and the market size is expected to reach nearly US$ 16.35 Bn. by 2029.

Drugs of Abuse Testing Market Overview

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

Drugs of Abuse Testing Market

To know about the Research Methodology   :- Request Free Sample Report

Drivers and Restrains:

Drugs of abuse (DOA) testing is found to be a clinical screening procedure to detect one or more illegal substances like drug, chemical, or plant product. This clinical screening procedure is performed to confirm the presence of one or more illegal or prescription drugs in the patient's urine, saliva, blood, hair or sweat. The surge in consumption alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for the drug abuse testing market.

Technological improvements toward the development of more accurate and precise testing devices and stringent government regulations mandating drug screening boost the market growth. Recently, the standard of living is pushing the adults towards drugs of abuse testing, and to rescue the adults from DOA the government as well as corporate companies are encouraging the DOA testing.

Lack of awareness and consideration of drug testing as a breach of privacy rights in certain countries hamper the growth of the global drug abuse testing market. Developing markets such as the Asia-Pacific, Latin America and Middle East Africa to provide beneficial opportunities for the drug abuse testing market growth.

Manufacturers in the drugs of abuse testing are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic merger, acquisitions and technological innovations are also the key focus areas of the manufacturers.

Segmentation Analysis:

Based on sample type, the drug abuse testing market is segmented into urine, hair, oral fluid, and breath. The urine segment accounted highest market revenue in 2021 and is expected to maintain its dominance during forecast period. This is ascribed to the lower price of urine sample analysis, availability in sufficient quantities, presence in higher concentrations of drugs abuse testing, metabolites and availability of point of care tests.

Drugs of Abuse Testing Market

Regional Analysis:

Geographically, global drugs of abuse testing market has been segmented into North America, Europe, Asia Pacific, and Latin America, and Middle East and Africa. In 2021, North America has been accounted for xx% of the revenue share in the drug abuse testing market and is anticipated to grow at a CAGR of xx% during the forecast period of 2022-2029. The North America region is currently facing the Drug abuse problem, which lead to legal, financial, and health problems.

Therefore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a population is abusing drugs. For example, Patients and Communities Act of 2021 is the newest law applied by the U.S. Government for counter-acting drug abuse. There is also a high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.

The objective of the report is to present comprehensive analysis of global drugs of abuse testing market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding global drugs of abuse testing market dynamics, structure by analyzing the market segments, and project the global drugs of abuse testing market size. Clear representation of competitive analysis of key players by sample type, price, financial position, product portfolio, growth strategies, and regional presence in the global drugs of abuse testing market make the report investor’s guide.

Drugs of Abuse Testing Market Scope: Inquire before buying

Global Drugs of Abuse Testing Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US$ 9.35 Bn.
Forecast Period 2023 to 2029 CAGR: 8.30% Market Size in 2029: US$ 16.35 Bn.
Segments Covered: by Product & Service Analyzers
Rapid testing devices
Consumables
Laboratory services
by Sample Type Urine
Hair
Oral fluid
Breath
by End Users Workplaces & Schools
Criminal Justice Systems and Law Enforcement Agencies
Research Laboratories
Hospitals

Drugs of Abuse Testing Market, by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)

Key Players:

1.Drägerwerk AG & Co. KGAA
2.Abbott Laboratories
3.Hoffmann-La Roche AG
4.Biorad Laboratories, Inc.
5.Siemens AG
6.Thermo Fisher Scientific, Inc.
7.Danaher Corporation
8.Quest Diagnostics Incorporated
9.Express Diagnostics International Inc.
10.OraSure
11.Alfa Scientific Designs
12.Premier Biotech
13.Shimadzu
14.Psychemedics
15.SureHire
16.CannAmm
17.Omega Laboratories
18.Merck KGaA
19.bioMérieux S.A.
20.Waters Corporation
21.Roche Holding AG
22.Laboratory Corporation of America Holdings
23.Alere Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Drugs of Abuse Testing Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Drugs of Abuse Testing Market?
Ans: The Global Market is growing at a CAGR of 8.30% during forecasting period 2023-2029.

3. What is scope of the Global Drugs of Abuse Testing Market report?
Ans: Global Drugs of Abuse Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. What is the study period of this Market?
Ans: The Global Drugs of Abuse Testing Market is studied from 2022 to 2029.

Table of Contents

Global Drugs of Abuse Testing Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Drugs of Abuse Testing Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Drugs of Abuse Testing Market Analysis and Forecast 6.1. Global Drugs of Abuse Testing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Drugs of Abuse Testing Market Analysis and Forecast, by Product & Service 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 7.4. Global Drugs of Abuse Testing Market Size (US$ Bn) Forecast, by Product & Service 7.5. Global Drugs of Abuse Testing Market Analysis, by Product & Service 7.6. Global Drugs of Abuse Testing Market Attractiveness Analysis, by Product & Service 8. Global Drugs of Abuse Testing Market Analysis and Forecast, by Sample Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 8.4. Global Drugs of Abuse Testing Market Size (US$ Bn) Forecast, by Sample Type 8.5. Global Drugs of Abuse Testing Market Analysis, by Sample Type 8.6. Global Drugs of Abuse Testing Market Attractiveness Analysis, by Sample Type 9. Global Drugs of Abuse Testing Market Analysis and Forecast, by End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Drugs of Abuse Testing Market Value Share Analysis, by End-User 9.4. Global Drugs of Abuse Testing Market Size (US$ Bn) Forecast, by End-User 9.5. Global Drugs of Abuse Testing Market Analysis, by End-User 9.6. Global Drugs of Abuse Testing Market Attractiveness Analysis, by End-User 10. Global Drugs of Abuse Testing Market Analysis, by Region 10.1. Global Drugs of Abuse Testing Market Value Share Analysis, by Region 10.2. Global Drugs of Abuse Testing Market Size (US$ Bn) Forecast, by Region 10.3. Global Drugs of Abuse Testing Market Attractiveness Analysis, by Region 11. North America Drugs of Abuse Testing Market Analysis 11.1. Key Findings 11.2. North America Drugs of Abuse Testing Market Overview 11.3. North America Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 11.4. North America Drugs of Abuse Testing Market Forecast, by Product & Service 11.4.1. Analyzers 11.4.2. Rapid testing devices 11.4.3. Consumables 11.4.4. Laboratory services 11.5. North America Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 11.6. North America Drugs of Abuse Testing Market Forecast, by Sample Type 11.6.1. Urine 11.6.2. Hair 11.6.3. Oral fluid 11.6.4. Breath 11.7. North America Drugs of Abuse Testing Market Value Share Analysis, by End-User 11.8. North America Drugs of Abuse Testing Market Forecast, by End-User 11.8.1. Workplaces & Schools 11.8.2. Criminal Justice Systems and Law 11.8.3. Enforcement Agencies 11.8.4. Research Laboratories 11.8.5. Hospitals 11.9. North America Drugs of Abuse Testing Market Value Share Analysis, by Country 11.10. North America Drugs of Abuse Testing Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Drugs of Abuse Testing Market Analysis, by Country 11.12. U.S. Drugs of Abuse Testing Market Forecast, by Product & Service 11.12.1. Analyzers 11.12.2. Rapid testing devices 11.12.3. Consumables 11.12.4. Laboratory services 11.13. U.S. Drugs of Abuse Testing Market Forecast, by Sample Type 11.13.1. Urine 11.13.2. Hair 11.13.3. Oral fluid 11.13.4. Breath 11.14. U.S. Drugs of Abuse Testing Market Forecast, by End-User 11.14.1. Workplaces & Schools 11.14.2. Criminal Justice Systems and Law 11.14.3. Enforcement Agencies 11.14.4. Research Laboratories 11.14.5. Hospitals 11.15. Canada Drugs of Abuse Testing Market Forecast, by Product & Service 11.15.1. Analyzers 11.15.2. Rapid testing devices 11.15.3. Consumables 11.15.4. Laboratory services 11.16. Steel Canada Drugs of Abuse Testing Market Forecast, by Sample Type 11.16.1. Urine 11.16.2. Hair 11.16.3. Oral fluid 11.16.4. Breath 11.17. Canada Drugs of Abuse Testing Market Forecast, by End-User 11.17.1. Workplaces & Schools 11.17.2. Criminal Justice Systems and Law 11.17.3. Enforcement Agencies 11.17.4. Research Laboratories 11.17.5. Hospitals 11.18. North America Drugs of Abuse Testing Market Attractiveness Analysis 11.18.1. By Product & Service 11.18.2. By Sample Type 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Drugs of Abuse Testing Market Analysis 12.1. Key Findings 12.2. Europe Drugs of Abuse Testing Market Overview 12.3. Europe Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 12.4. Europe Drugs of Abuse Testing Market Forecast, by Product & Service 12.4.1. Analyzers 12.4.2. Rapid testing devices 12.4.3. Consumables 12.4.4. Laboratory services 12.5. Europe Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 12.6. Europe Drugs of Abuse Testing Market Forecast, by Sample Type 12.6.1. Urine 12.6.2. Hair 12.6.3. Oral fluid 12.6.4. Breath 12.7. Europe Drugs of Abuse Testing Market Value Share Analysis, by End-User 12.8. Europe Drugs of Abuse Testing Market Forecast, by End-User 12.8.1. Workplaces & Schools 12.8.2. Criminal Justice Systems and Law 12.8.3. Enforcement Agencies 12.8.4. Research Laboratories 12.8.5. Hospitals 12.9. Europe Drugs of Abuse Testing Market Value Share Analysis, by Country 12.10. Europe Drugs of Abuse Testing Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Drugs of Abuse Testing Market Analysis, by Country 12.12. Germany Drugs of Abuse Testing Market Forecast, by Product & Service 12.12.1. Analyzers 12.12.2. Rapid testing devices 12.12.3. Consumables 12.12.4. Laboratory services 12.13. Germany Drugs of Abuse Testing Market Forecast, by Sample Type 12.13.1. Urine 12.13.2. Hair 12.13.3. Oral fluid 12.13.4. Breath 12.14. Germany Drugs of Abuse Testing Market Forecast, by End-User 12.14.1. Workplaces & Schools 12.14.2. Criminal Justice Systems and Law 12.14.3. Enforcement Agencies 12.14.4. Research Laboratories 12.14.5. Hospitals 12.15. U.K. Drugs of Abuse Testing Market Forecast, by Product & Service 12.15.1. Analyzers 12.15.2. Rapid testing devices 12.15.3. Consumables 12.15.4. Laboratory services 12.16. U.K. Drugs of Abuse Testing Market Forecast, by Sample Type 12.16.1. Urine 12.16.2. Hair 12.16.3. Oral fluid 12.16.4. Breath 12.17. U.K. Drugs of Abuse Testing Market Forecast, by End-User 12.17.1. Workplaces & Schools 12.17.2. Criminal Justice Systems and Law 12.17.3. Enforcement Agencies 12.17.4. Research Laboratories 12.17.5. Hospitals 12.18. France Drugs of Abuse Testing Market Forecast, by Product & Service 12.18.1. Analyzers 12.18.2. Rapid testing devices 12.18.3. Consumables 12.18.4. Laboratory services 12.19. France Drugs of Abuse Testing Market Forecast, by Sample Type 12.19.1. Urine 12.19.2. Hair 12.19.3. Oral fluid 12.19.4. Breath 12.20. France Drugs of Abuse Testing Market Forecast, by End-User 12.20.1. Workplaces & Schools 12.20.2. Criminal Justice Systems and Law 12.20.3. Enforcement Agencies 12.20.4. Research Laboratories 12.20.5. Hospitals 12.21. Italy Drugs of Abuse Testing Market Forecast, by Product & Service 12.21.1. Analyzers 12.21.2. Rapid testing devices 12.21.3. Consumables 12.21.4. Laboratory services 12.22. Italy Drugs of Abuse Testing Market Forecast, by Sample Type 12.22.1. Urine 12.22.2. Hair 12.22.3. Oral fluid 12.22.4. Breath 12.23. Italy Drugs of Abuse Testing Market Forecast, by End-User 12.23.1. Workplaces & Schools 12.23.2. Criminal Justice Systems and Law 12.23.3. Enforcement Agencies 12.23.4. Research Laboratories 12.23.5. Hospitals 12.24. Spain Drugs of Abuse Testing Market Forecast, by Product & Service 12.24.1. Analyzers 12.24.2. Rapid testing devices 12.24.3. Consumables 12.24.4. Laboratory services 12.25. Spain Drugs of Abuse Testing Market Forecast, by Sample Type 12.25.1. Urine 12.25.2. Hair 12.25.3. Oral fluid 12.25.4. Breath 12.26. Spain Drugs of Abuse Testing Market Forecast, by End-User 12.26.1. Workplaces & Schools 12.26.2. Criminal Justice Systems and Law 12.26.3. Enforcement Agencies 12.26.4. Research Laboratories 12.26.5. Hospitals 12.27. Rest of Europe Drugs of Abuse Testing Market Forecast, by Product & Service 12.27.1. Analyzers 12.27.2. Rapid testing devices 12.27.3. Consumables 12.27.4. Laboratory services 12.28. Rest of Europe Drugs of Abuse Testing Market Forecast, by Sample Type 12.28.1. Urine 12.28.2. Hair 12.28.3. Oral fluid 12.28.4. Breath 12.29. Rest Of Europe Drugs of Abuse Testing Market Forecast, by End-User 12.29.1. Workplaces & Schools 12.29.2. Criminal Justice Systems and Law 12.29.3. Enforcement Agencies 12.29.4. Research Laboratories 12.29.5. Hospitals 12.30. Europe Drugs of Abuse Testing Market Attractiveness Analysis 12.30.1. By Product & Service 12.30.2. By Sample Type 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Drugs of Abuse Testing Market Analysis 13.1. Key Findings 13.2. Asia Pacific Drugs of Abuse Testing Market Overview 13.3. Asia Pacific Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 13.4. Asia Pacific Drugs of Abuse Testing Market Forecast, by Product & Service 13.4.1. Analyzers 13.4.2. Rapid testing devices 13.4.3. Consumables 13.4.4. Laboratory services 13.5. Asia Pacific Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 13.6. Asia Pacific Drugs of Abuse Testing Market Forecast, by Sample Type 13.6.1. Urine 13.6.2. Hair 13.6.3. Oral fluid 13.6.4. Breath 13.7. Asia Pacific Drugs of Abuse Testing Market Value Share Analysis, by End-User 13.8. Asia Pacific Drugs of Abuse Testing Market Forecast, by End-User 13.8.1. Workplaces & Schools 13.8.2. Criminal Justice Systems and Law 13.8.3. Enforcement Agencies 13.8.4. Research Laboratories 13.8.5. Hospitals 13.9. Asia Pacific Drugs of Abuse Testing Market Value Share Analysis, by Country 13.10. Asia Pacific Drugs of Abuse Testing Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Drugs of Abuse Testing Market Analysis, by Country 13.12. China Drugs of Abuse Testing Market Forecast, by Product & Service 13.12.1. Analyzers 13.12.2. Rapid testing devices 13.12.3. Consumables 13.12.4. Laboratory services 13.13. China Drugs of Abuse Testing Market Forecast, by Sample Type 13.13.1. Urine 13.13.2. Hair 13.13.3. Oral fluid 13.13.4. Breath 13.14. China Drugs of Abuse Testing Market Forecast, by End-User 13.14.1. Workplaces & Schools 13.14.2. Criminal Justice Systems and Law 13.14.3. Enforcement Agencies 13.14.4. Research Laboratories 13.14.5. Hospitals 13.15. India Drugs of Abuse Testing Market Forecast, by Product & Service 13.15.1. Analyzers 13.15.2. Rapid testing devices 13.15.3. Consumables 13.15.4. Laboratory services 13.16. India Drugs of Abuse Testing Market Forecast, by Sample Type 13.16.1. Urine 13.16.2. Hair 13.16.3. Oral fluid 13.16.4. Breath 13.17. India Drugs of Abuse Testing Market Forecast, by End-User 13.17.1. Workplaces & Schools 13.17.2. Criminal Justice Systems and Law 13.17.3. Enforcement Agencies 13.17.4. Research Laboratories 13.17.5. Hospitals 13.18. Japan Drugs of Abuse Testing Market Forecast, by Product & Service 13.18.1. Analyzers 13.18.2. Rapid testing devices 13.18.3. Consumables 13.18.4. Laboratory services 13.19. Japan Drugs of Abuse Testing Market Forecast, by Sample Type 13.19.1. Urine 13.19.2. Hair 13.19.3. Oral fluid 13.19.4. Breath 13.20. Japan Drugs of Abuse Testing Market Forecast, by End-User 13.20.1. Workplaces & Schools 13.20.2. Criminal Justice Systems and Law 13.20.3. Enforcement Agencies 13.20.4. Research Laboratories 13.20.5. Hospitals 13.21. ASEAN Drugs of Abuse Testing Market Forecast, by Product & Service 13.21.1. Analyzers 13.21.2. Rapid testing devices 13.21.3. Consumables 13.21.4. Laboratory services 13.22. ASEAN Drugs of Abuse Testing Market Forecast, by Sample Type 13.22.1. Urine 13.22.2. Hair 13.22.3. Oral fluid 13.22.4. Breath 13.23. ASEAN Drugs of Abuse Testing Market Forecast, by End-User 13.23.1. Workplaces & Schools 13.23.2. Criminal Justice Systems and Law 13.23.3. Enforcement Agencies 13.23.4. Research Laboratories 13.23.5. Hospitals 13.24. Rest of Asia Pacific Drugs of Abuse Testing Market Forecast, by Product & Service 13.24.1. Analyzers 13.24.2. Rapid testing devices 13.24.3. Consumables 13.24.4. Laboratory services 13.25. Rest of Asia Pacific Drugs of Abuse Testing Market Forecast, by Sample Type 13.25.1. Urine 13.25.2. Hair 13.25.3. Oral fluid 13.25.4. Breath 13.26. Rest of Asia Pacific Drugs of Abuse Testing Market Forecast, by End-User 13.26.1. Workplaces & Schools 13.26.2. Criminal Justice Systems and Law 13.26.3. Enforcement Agencies 13.26.4. Research Laboratories 13.26.5. Hospitals 13.27. Asia Pacific Drugs of Abuse Testing Market Attractiveness Analysis 13.27.1. By Product & Service 13.27.2. By Sample Type 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Drugs of Abuse Testing Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Drugs of Abuse Testing Market Overview 14.3. Middle East & Africa Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 14.4. Middle East & Africa Drugs of Abuse Testing Market Forecast, by Product & Service 14.4.1. Analyzers 14.4.2. Rapid testing devices 14.4.3. Consumables 14.4.4. Laboratory services 14.5. Middle East & Africa Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 14.6. Middle East & Africa Drugs of Abuse Testing Market Forecast, by Sample Type 14.6.1. Urine 14.6.2. Hair 14.6.3. Oral fluid 14.6.4. Breath 14.7. Middle East & Africa Drugs of Abuse Testing Market Value Share Analysis, by End-User 14.8. Middle East & Africa Drugs of Abuse Testing Market Forecast, by End-User 14.8.1. Workplaces & Schools 14.8.2. Criminal Justice Systems and Law 14.8.3. Enforcement Agencies 14.8.4. Research Laboratories 14.8.5. Hospitals 14.9. Middle East & Africa Drugs of Abuse Testing Market Value Share Analysis, by Country 14.10. Middle East & Africa Drugs of Abuse Testing Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Drugs of Abuse Testing Market Analysis, by Country 14.12. GCC Drugs of Abuse Testing Market Forecast, by Product & Service 14.12.1. Analyzers 14.12.2. Rapid testing devices 14.12.3. Consumables 14.12.4. Laboratory services 14.13. GCC Drugs of Abuse Testing Market Forecast, by Sample Type 14.13.1. Urine 14.13.2. Hair 14.13.3. Oral fluid 14.13.4. Breath 14.14. GCC Drugs of Abuse Testing Market Forecast, by End-User 14.14.1. Workplaces & Schools 14.14.2. Criminal Justice Systems and Law 14.14.3. Enforcement Agencies 14.14.4. Research Laboratories 14.14.5. Hospitals 14.15. South Africa Drugs of Abuse Testing Market Forecast, by Product & Service 14.15.1. Analyzers 14.15.2. Rapid testing devices 14.15.3. Consumables 14.15.4. Laboratory services 14.16. South Africa Drugs of Abuse Testing Market Forecast, by Sample Type 14.16.1. Urine 14.16.2. Hair 14.16.3. Oral fluid 14.16.4. Breath 14.17. South Africa Drugs of Abuse Testing Market Forecast, by End-User 14.17.1. Workplaces & Schools 14.17.2. Criminal Justice Systems and Law 14.17.3. Enforcement Agencies 14.17.4. Research Laboratories 14.17.5. Hospitals 14.18. Rest of Middle East & Africa Drugs of Abuse Testing Market Forecast, by Product & Service 14.18.1. Analyzers 14.18.2. Rapid testing devices 14.18.3. Consumables 14.18.4. Laboratory services 14.19. Rest of Middle East & Africa Drugs of Abuse Testing Market Forecast, by Sample Type 14.19.1. Urine 14.19.2. Hair 14.19.3. Oral fluid 14.19.4. Breath 14.20. Rest of Middle East & Africa Drugs of Abuse Testing Market Forecast, by End-User 14.20.1. Workplaces & Schools 14.20.2. Criminal Justice Systems and Law 14.20.3. Enforcement Agencies 14.20.4. Research Laboratories 14.20.5. Hospitals 14.21. Middle East & Africa Drugs of Abuse Testing Market Attractiveness Analysis 14.21.1. By Product & Service 14.21.2. By Sample Type 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Drugs of Abuse Testing Market Analysis 15.1. Key Findings 15.2. South America Drugs of Abuse Testing Market Overview 15.3. South America Drugs of Abuse Testing Market Value Share Analysis, by Product & Service 15.4. South America Drugs of Abuse Testing Market Forecast, by Product & Service 15.4.1. Analyzers 15.4.2. Rapid testing devices 15.4.3. Consumables 15.4.4. Laboratory services 15.5. South America Drugs of Abuse Testing Market Value Share Analysis, by Sample Type 15.6. South America Drugs of Abuse Testing Market Forecast, by Sample Type 15.6.1. Urine 15.6.2. Hair 15.6.3. Oral fluid 15.6.4. Breath 15.7. South America Drugs of Abuse Testing Market Value Share Analysis, by End-User 15.8. South America Drugs of Abuse Testing Market Forecast, by End-User 15.8.1. Workplaces & Schools 15.8.2. Criminal Justice Systems and Law 15.8.3. Enforcement Agencies 15.8.4. Research Laboratories 15.8.5. Hospitals 15.9. South America Drugs of Abuse Testing Market Value Share Analysis, by Country 15.10. South America Drugs of Abuse Testing Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Drugs of Abuse Testing Market Analysis, by Country 15.12. Brazil Drugs of Abuse Testing Market Forecast, by Product & Service 15.12.1. Analyzers 15.12.2. Rapid testing devices 15.12.3. Consumables 15.12.4. Laboratory services 15.13. Brazil Drugs of Abuse Testing Market Forecast, by Sample Type 15.13.1. Urine 15.13.2. Hair 15.13.3. Oral fluid 15.13.4. Breath 15.14. Brazil Drugs of Abuse Testing Market Forecast, by End-User 15.14.1. Workplaces & Schools 15.14.2. Criminal Justice Systems and Law 15.14.3. Enforcement Agencies 15.14.4. Research Laboratories 15.14.5. Hospitals 15.15. Mexico Drugs of Abuse Testing Market Forecast, by Product & Service 15.15.1. Analyzers 15.15.2. Rapid testing devices 15.15.3. Consumables 15.15.4. Laboratory services 15.16. Mexico Drugs of Abuse Testing Market Forecast, by Sample Type 15.16.1. Urine 15.16.2. Hair 15.16.3. Oral fluid 15.16.4. Breath 15.17. Mexico Drugs of Abuse Testing Market Forecast, by End-User 15.17.1. Workplaces & Schools 15.17.2. Criminal Justice Systems and Law 15.17.3. Enforcement Agencies 15.17.4. Research Laboratories 15.17.5. Hospitals 15.18. Rest of South America Drugs of Abuse Testing Market Forecast, by Product & Service 15.18.1. Analyzers 15.18.2. Rapid testing devices 15.18.3. Consumables 15.18.4. Laboratory services 15.19. Rest of South America Drugs of Abuse Testing Market Forecast, by Sample Type 15.19.1. Urine 15.19.2. Hair 15.19.3. Oral fluid 15.19.4. Breath 15.20. Rest of South America Drugs of Abuse Testing Market Forecast, by End-User 15.20.1. Workplaces & Schools 15.20.2. Criminal Justice Systems and Law 15.20.3. Enforcement Agencies 15.20.4. Research Laboratories 15.20.5. Hospitals 15.21. South America Drugs of Abuse Testing Market Attractiveness Analysis 15.21.1. By Product & Service 15.21.2. By Sample Type 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Drägerwerk AG & Co. KGAA 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Abbott Laboratories 16.3.3. Hoffmann-La Roche AG 16.3.4. Biorad Laboratories, Inc. 16.3.5. Siemens AG 16.3.6. Thermo Fisher Scientific, Inc. 16.3.7. Danaher Corporation 16.3.8. Quest Diagnostics Incorporated 16.3.9. Express Diagnostics International Inc. 16.3.10. OraSure 16.3.11. Alfa Scientific Designs 16.3.12. Premier Biotech 16.3.13. Shimadzu 16.3.14. Psychemedics 16.3.15. SureHire 16.3.16. CannAmm 16.3.17. Omega Laboratories 16.3.18. Merck KGaA 16.3.19. bioMérieux S.A. 16.3.20. Waters Corporation 16.3.21. Roche Holding AG 16.3.22. Laboratory Corporation of America Holdings 16.3.23. Alere Inc. 17. Primary Key Insights